PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • IOLs • Phacoemulsification devices • OVDs • Femtosecond lasers • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Hospitals • Ophthalmology clinics • ASCs PART 10: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Cataract surgery devices market in Americas • Cataract surgery devices market in EMEA • Cataract surgery devices market in APAC • Market opportunity PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 13: MARKET TRENDS • Increasing medical tourism for low cost cataract surgery • Increasing access to cataract surgery in emerging markets • Increasing strategic collaborations and M&A PART 14: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive landscape PART 15: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Carl Zeiss Meditec • HOYA • Johnson & Johnson • NIDEK • Novartis • Valeant Pharmaceuticals PART 16: APPENDIX • List of abbreviations     Exhibit 01: Global ophthalmology devices market Exhibit 02: Global ophthalmology devices market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Global cataract surgery devices market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global cataract surgery devices market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global cataract surgery devices market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Global cataract surgery devices market share by product – 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Global IOLs market – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Global IOLs market – Year-over-year growth 2018-2022 (%) Exhibit 22: Global phacoemulsification devices market – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Global phacoemulsification devices market – Year-over-year growth 2018-2022 (%) Exhibit 24: Global OVDs market – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Global OVDs market – Year-over-year growth 2018-2022 (%) Exhibit 26: Global femtosecond lasers market – Market size and forecast 2017-2022 ($ mn) Exhibit 27: Global femtosecond lasers market – Year-over-year growth 2018-2022 (%) Exhibit 28: Market opportunity by product Exhibit 29: Customer landscape Exhibit 30: Global cataract surgery devices market share by end-user (%) in 2017 Exhibit 31: Global cataract surgery devices market– Market share by geography 2017-2022 (%) Exhibit 32: Regional comparison Exhibit 33: Cataract surgery devices market in Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 34: Cataract surgery devices market in Americas – Year-over-year growth 2018-2022 (%) Exhibit 35: Top 3 countries in Americas Exhibit 36: Cataract surgery devices market in EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 37: Cataract surgery devices market EMEA – Year-over-year growth 2018-2022 (%) Exhibit 38: Top 3 countries in EMEA Exhibit 39: Cataract surgery devices market in APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 40: Cataract surgery devices market in APAC – Year-over-year growth 2018-2022 (%) Exhibit 41: Top 3 countries in APAC Exhibit 42: Market opportunity Exhibit 43: Vendor landscape Exhibit 44: Landscape disruption Exhibit 45: Vendors covered Exhibit 46: Vendor classification Exhibit 47: Market positioning of vendors Exhibit 48: Carl Zeiss Meditec – Overview Exhibit 49: Carl Zeiss Meditec – Business segments Exhibit 50: Carl Zeiss Meditec – Organizational developments Exhibit 51: Carl Zeiss Meditec – Geographic focus Exhibit 52: Carl Zeiss Meditec – Segment focus Exhibit 53: Carl Zeiss Meditec – Key offerings Exhibit 54: Carl Zeiss Meditec – Key customers Exhibit 55: HOYA – Overview Exhibit 56: HOYA – Business segments Exhibit 57: HOYA – Organizational developments Exhibit 58: HOYA – Geographic focus Exhibit 59: HOYA – Segment focus Exhibit 60: HOYA – Key offerings Exhibit 61: HOYA – Key customers Exhibit 62: Johnson & Johnson – Overview Exhibit 63: Johnson & Johnson – Business segments Exhibit 64: Johnson & Johnson – Organizational developments Exhibit 65: Johnson & Johnson – Geographic focus Exhibit 66: Johnson & Johnson – Segment focus Exhibit 67: Johnson & Johnson – Key offerings Exhibit 68: Johnson & Johnson – Key customers Exhibit 69: NIDEK – Overview Exhibit 70: NIDEK – Business segments Exhibit 71: NIDEK – Organizational developments Exhibit 72: NIDEK – Geographic focus Exhibit 73: NIDEK – Segment focus Exhibit 74: NIDEK – Key offerings Exhibit 75: NIDEK – Key customers Exhibit 76: Novartis – Overview Exhibit 77: Novartis – Business segments Exhibit 78: Novartis – Organizational developments Exhibit 79: Novartis – Geographic focus Exhibit 80: Novartis – Segment focus Exhibit 81: Novartis – Key offerings Exhibit 82: Novartis – Key customers Exhibit 83: Valeant Pharmaceuticals – Overview Exhibit 84: Valeant Pharmaceuticals – Business segments Exhibit 85: Valeant Pharmaceuticals – Organizational developments Exhibit 86: Valeant Pharmaceuticals – Geographic focus Exhibit 87: Valeant Pharmaceuticals – Segment focus Exhibit 88: Valeant Pharmaceuticals – Key offerings Exhibit 89: Valeant Pharmaceuticals – Key customers

Carl Zeiss Meditec HOYA Johnson & Johnson NIDEK Novartis Valeant Pharmaceuticals